Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Mar 5;21(5):1767.
doi: 10.3390/ijms21051767.

Counteracting Radio-Resistance Using the Optimization of Radiotherapy

François Chevalier  1   2   3
Affiliations
Editorial

Counteracting Radio-Resistance Using the Optimization of Radiotherapy

François Chevalier. Int J Mol Sci. .

Abstract

Radiotherapy is an essential component of cancer therapy and remains one of the most (cost-) effective treatment options available [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Wang Y., Sauvat A., Lacrouts C., Lebeau J., Grall R., Hullo M., Nesslany F., Chevillard S. TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy. Int. J. Mol. Sci. 2020;21:940. doi: 10.3390/ijms21030940. - DOI - PMC - PubMed
    1. Darwis N.D.M., Nachankar A., Sasaki Y., Matsui T., Noda S., Murata K., Tamaki T., Ando K., Okonogi N., Shiba S., et al. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy. Int. J. Mol. Sci. 2019;20:4563. doi: 10.3390/ijms20184563. - DOI - PMC - PubMed
    1. Anakura M., Nachankar A., Kobayashi D., Amornwichet N., Hirota Y., Shibata A., Oike T., Nakano T. Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses. Int. J. Mol. Sci. 2019;20:3635. doi: 10.3390/ijms20153635. - DOI - PMC - PubMed
    1. Thariat J., Valable S., Laurent C., Haghdoost S., Pérès E.A., Bernaudin M., Sichel F., Lesueur P., Césaire M., Petit E., et al. Hadrontherapy Interactions in Molecular and Cellular Biology. Int. J. Mol. Sci. 2020;21:133. doi: 10.3390/ijms21010133. - DOI - PMC - PubMed
    1. Matsui T., Nuryadi E., Komatsu S., Hirota Y., Shibata A., Oike T., Nakano T. Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity. Int. J. Mol. Sci. 2019;20:4148. doi: 10.3390/ijms20174148. - DOI - PMC - PubMed

Publication types